Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

30.49 +0.21 (+0.69%)
Streaming Delayed Price Updated: 1:00 PM EDT, Jul 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Moderna, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Exploring the top movers within the S&P500 index during today's session.
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Discover which S&P500 stocks are making waves on Wednesday.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Wednesday's pre-market session: top gainers and losers in the S&P500 index
As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment. 
Via Chartmill
Coatue's Philippe Laffont Just Bought Shares of This Beaten-Down Growth Stock That Wall Street Predicts Will Soar 80%
Via The Motley Fool
Moderna Unusual Options Activity
Via Benzinga
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
Via The Motley Fool
Behind the Scenes of Moderna's Latest Options Trends
Via Benzinga
Spotting Winners: Sarepta Therapeutics (NASDAQ:SRPT) And Therapeutics Stocks In Q4
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers. 
Via StockStory
Topics Artificial Intelligence
1 Healthcare Stock to Own for Decades and 2 to Ignore
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory... 
Via StockStory
Topics Stocks
3 Beaten-Down Biotech Stocks to Buy Before They Soar. Wall Street Is Predicting Jumps of 68% to 250%.
Via The Motley Fool
Moderna Stock Heads For Weekly Loss As Retail Caution Prevails: Wealth Advisor Tells Why She's Staying On The Sidelines
The stock fell over 7% on Thursday after reports that federal health officials under the Trump administration are re-evaluating Moderna's $590 million contract for bird flu vaccine development. 
Via Stocktwits
Topics Government
Moderna Tumbles As RFK Jr. Reportedly Mulls Pulling $590 Million In Bird Flu Funds
Moderna is under pressure as two of its vaccines hit potential snags. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Gapping S&P500 stocks in Thursday's session
Stay updated with the S&P500 gap up and gap down stocks on Thursday. Get a glimpse of the market's movement during today's session. 
Via Chartmill
Get insights into the top movers in the S&P500 index of Thursday's pre-market session.
Curious about the S&P500 stocks that are showing activity before the opening bell on Thursday? 
Via Chartmill
Trump's Officials To Re-Consider Moderna's $590 Million Bird Flu Vaccine Funding: RFK Jr-Led HHS Slams 'Biden Administration's Failed Oversight'
The Donald Trump administration is contemplating the withdrawal of a $590 million contract previously granted to Moderna Inc. (NASDAQ: MRNA) by the Biden administration. This contract was intended for... 
Via Benzinga
Topics Government
Uncover the latest developments among S&P500 stocks in today's session.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Let's have a look at the top S&P500 gainers and losers in the middle of the day of today's session. 
Via Chartmill
Which S&P500 stocks are gapping on Monday?
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Monday and stay ahead of the market trends. 
Via Chartmill
Bill Gates Says 'Next Pandemic Can Emerge Anywhere' And The World Isn't Prepared: 'We Can't Afford To Get Caught Flat-Footed Again'
Via Benzinga
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst
Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH. 
Via Benzinga
Market Monitor February 24th
Wall Street Slumps Amid Consumer Worries and New Virus Concerns from China 
Via Chartmill
10 Worst Performing Large-Caps Last 12 Months
Here’s this week’s top 10 worst performing Large-Caps in the last twelve months. 
Via Talk Markets
Topics Stocks / Equities
Uncover the latest developments among S&P500 stocks in today's session.
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So.
Via The Motley Fool
Moderna: A Generational Opportunity for Investors in 2025
Moderna had a weak quarter but reaffirmed guidance, expecting three new product approvals in 2025 and as many as ten more within three years. 
Via MarketBeat
Uncover the latest developments among S&P500 stocks in today's session.
Curious about the S&P500 stocks that are in motion on Tuesday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Why Moderna (MRNA) Stock Is Up Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 11.8% in the morning session after it continued to build on the 3% gain from Friday when it reported fourth-quarter 2024 financial results.... 
Via StockStory
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Analyst Confident In Moderna's Cancer Vaccine But Highlights Other Challenges
Moderna misses Q4 EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake challenges. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.